GHTF (Global Harmonisation Task Force) issues two new documents on global reporting
This article was originally published in Clinica
Executive Summary
The goal of making adverse incident reporting an increasingly global phenomenon is becoming ever more attainable as Study Group 2 of the Global Harmonisation Task Force, covering medical device vigilance and post-market surveillance, continues to endorse documents that will encourage the convergence and compatibility of reporting activities throughout the world.